Protein inhibitors: cracking the code of disease mechanisms
Explore how protein inhibitors revolutionize disease understanding, by unlocking the secrets of disease pathways.
Sponsored
- Latest Posts
More sustainable drug development and lab sustainability
From reducing carbon footprints to optimising costs, explore innovative solutions for sustainable drug discovery and development!
Mastering biologics tech transfer: key success factors
Unlock the secrets of efficient tech transfers for biologics, and explore critical stages and success factors.
How to find lab space as a startup
Optimizing early discovery by unraveling cancer complexity within precision therapeutics
20 years of BIOSPAIN – The evolution of an international biotech event
ADVERTISEMENT
ADVERTISEMENT
Separation and analysis of empty and filled capsids during viral vector production
How is Quantoom Biosciences’ Ntensify™ technology changing mRNA production?
Becoming human: GMP-compliant supplements for cell therapy
8 life science innovators you must meet at BioTrinity 2023
BIO-Europe Spring 2023: The Highlights
BIO-Europe Spring is one of Europe’s biggest biotech partnering events with discussion topics ranging from platform technologies and manufacturing to biotech investments. Here are some of the key take-home reports from the proceedings. The event, which took place from March 20 to 22, in the budding biotech hub of Basel, Switzerland, was in full swing […]
Infographic: Why choosing a client-centric CTDMO is critical when outsourcing biomanufacturing projects
In 2021, 28% of FDA approvals were granted to biologic drugs, showcasing the increasing demand for the biopharma industry to develop, manufacture and market biologic-based therapies. Biologic drugs include monoclonal antibodies and large molecules produced in mammalian cells, bringing the already complex process of drug development to a new level. Although the biomanufacturing of many […]
ADVERTISEMENT
